Characteristic | TCGA cohort | GSE40967 cohort | |||
---|---|---|---|---|---|
No.of patients | Percentage (%) | No.of patients | Percentage (%) | ||
Age |  < 60 | 122 | 26.99 | 153 | 26.15 |
 ≥ 60 | 330 | 73.01 | 432 | 73.85 | |
Gender | Male | 238 | 52.65 | 322 | 55.04 |
Female | 214 | 47.35 | 263 | 44.96 | |
Clinical stage | I | 76 | 16.81 | 42 | 7.18 |
II | 178 | 39.39 | 271 | 46.32 | |
III | 125 | 27.65 | 210 | 35.90 | |
IV | 62 | 13.72 | 60 | 10.26 | |
Unknown | 11 | 2.43 | 2 | 0.34 | |
T stage | T1 | 10 | 2.21 | 16 | 2.74 |
T2 | 77 | 17.04 | 49 | 8.38 | |
T3 | 308 | 68.14 | 379 | 64.78 | |
T4 | 57 | 12.61 | 119 | 20.34 | |
Unknown | 0 | 0 | 22 | 3.76 | |
N stage | N0 | 269 | 59.51 | 314 | 53.68 |
N1 | 103 | 22.79 | 137 | 23.42 | |
N2 | 80 | 17.70 | 106 | 18.12 | |
Unknown | 0 | 0 | 28 | 4.78 | |
M stage | M0 | 334 | 73.89 | 499 | 85.30 |
M1 | 62 | 13.72 | 61 | 10.43 | |
Mx | 49 | 10.84 | 3 | 0.51 | |
Unknown | 7 | 1.55 | 22 | 3.76 | |
Survival status | Alive | 364 | 80.53 | 395 | 67.52 |
Dead | 88 | 19.47 | 179 | 30.60 | |
Unknown | 0 | 0 | 11 | 1.88 |